Pulse wave velocity (PWV), augmentation index (Aix), and central aortic pressure (CAP) are arterial stiffness markers of endothelial dysfunction (ED). We investigated the relationship between arterial stiffness parameters and asymmetric dimethylarginine (ADMA; a marker of ED), in newly diagnosed patients with hypertension (n = 101; 61 females). These patients were investigated in accordance with the recommendations of hypertension guidelines. Arterial stiffness was measured, and serum ADMA and C-reactive protein (CRP; a marker of inflammation) levels were determined. In both women and men, there was no difference in terms of age, body mass index, systolic and diastolic blood pressures, PWV, CAP and the levels of ADMA, while Aix and CRP levels were significantly higher in women (P = .004, P = .046, respectively). In the whole group, ADMA levels correlated with Aix (Pearson r = .237, P = .024). Our findings provide further evidence of a link between arterial stiffness and ED in newly diagnosed patients with hypertension.
ManciaGFagardRNarkiewiczK. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J. 2013;34(28):2159–2219.
2.
Wolf-MaierKCooperRSBanegasJR. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363–2369.
Suchy-DiceyAMWallaceERS V ElkindM. Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. Am J Hypertens. 2013;26(10):1210–1217.
5.
GeronimusATBoundJWaidmannTAHillemeierMMBurnsPB. Excess mortality among blacks and whites in the United States. N Engl J Med. 1996;335(21):1552–1558.
6.
ChalmersJMacMahonSManciaG. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines subcommittee. Clin Exp Hypertens. 1999;17(2):151–183.
7.
MacMahonSPetoRCollinsR. Blood pressure, stroke, and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765–774.
8.
HeitzerTSchlinzigTKrohnKMeinertzTMünzelTMunzelT. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104(22):2673–2678.
9.
SchulzEGoriTMünzelT. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011;34(6):665–673.
10.
YilmazMISonmezASaglamM. Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease. Kidney Int. 2009;75(12):1316–1321.
11.
BögerRVallancePCookeJ. Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase. Atheroscler Suppl. 2003;4(4):1–3.
12.
YilmazMISonmezASaglamM. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. J Am Soc Nephrol. 2008;19(2):388–395.
13.
LandimMBPCasella FilhoAChagasACP. Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis. Clinics (Sao Paulo). 2009;64(5):471–478.
14.
YılmazMCarreroJJMartín-VenturaJL. Combined therapy with renin–angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation. Clin J Am Soc Nephrol. 2010;5(7):1174–1181.
15.
BautistaLELópez-JaramilloPVeraLMCasasJPOteroAPGuaracaoAI. Is C-reactive protein an independent risk factor for essential hypertension?J Hypertens. 2001;19(5):857–861.
16.
BautistaLE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens. 2003;17(4):223–230.
17.
LaurentSBoutouyriePAsmarR. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236–1241.
18.
Willum-HansenTStaessenJATorp-PedersenC. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113(5):664–670.
19.
MeaumeSBenetosAHenryOFRudnichiASafarME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001;21(12):2046–2050.
20.
KostisJBLawrence-NelsonJRanjanRWilsonACKostisWJLacyCR. Association of increased pulse pressure with the development of heart failure in SHEP. systolic hypertension in the elderly (SHEP) cooperative research group. Am J Hypertens. 2001;14(8 pt 1):798–803.
21.
ArslanECakarMSarlakH. Investigation of the aortic pulse wave velocity in patients with Gilbert’s syndrome. Clin Exp Hypertens. 2013;35(7):512–515. doi:10.3109/10641963.2012.758277.
22.
AltunBBulucuFDemirbasS. The relationship between some of the cardiovascular risk factors and arterial stiffness parameters in essentially hypertensive patients. Clin Exp Hypertens. 2013;35(6):444–448. doi:10.3109/10641963.2012.746354.
23.
FriedewaldWTLevyRIFredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
24.
SengstockDSandsRLGillespieBW. Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease. Nephrol Dial Transplant. 2010;25(3):853–861.
25.
KatsikiNKoumarasCAthyrosVGKaragiannisA. Thinking beyond traditional cardiovascular risk factors: the role of arterial stiffness in targeting residual risk. Angiology. 2012;63(1):9–11.
26.
KoharaKTabaraYOshiumiAMiyawakiYKobayashiTMikiT. Radial augmentation index: a useful and easily obtainable parameter for vascular aging. Am J Hypertens. 2005;18(1 pt 2):11S–14S.
27.
KielsteinJTZoccaliC. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?Am J Kidney Dis. 2005;46(2):186–202.
28.
DevarajSKumaresanPRJialalI. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol. 2004;36(3):405–410.
29.
ApikogluMBulucuFDemirbasS. The relationship between microalbuminuria, left ventricular hypertrophy, retinopathy, and sex hormone status in newly diagnosed hypertensive women. Clin Exp Hypertens. 2013;35(5):325–329. doi:10.3109/10641963.2012.721844.
30.
MatthanNRZhuLPencinaMD’AgostinoRBSchaeferEJLichtensteinAH. Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in framingham offspring study participants. J Am Heart Assoc. 2013;2(1):e005066.
31.
MaranonRReckelhoffJF. Sex and gender differences in control of blood pressure. Clin Sci (Lond). 2013;125(7):311–318.
32.
HaywardCSKellyRP. Gender-related differences in the central arterial pressure waveform. J Am Coll Cardiol. 1997;30(7):1863–1871.
33.
LondonGMGuerinAPPannierBMarchaisSJStimpelM. Influence of sex on arterial hemodynamics and blood pressure. role of body height. Hypertension. 1995;26(3):514–519.
34.
JatoiNAJerrard-DunnePFeelyJMahmudA. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension. 2007;49(5):981–985.
35.
Yu-JieWHui-LiangLBingLLuZZhi-GengJ. Impact of smoking and smoking cessation on arterial stiffness in healthy participants. Angiology. 2013;64(4):273–280.
36.
AthyrosVGKatsikiNDoumasMKaragiannisAMikhailidisDP. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr Med Res Opin. 2013;29(10):1263–1274.
37.
BleichSBleichKKroppS. Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the “French Paradox”?Alcohol Alcohol. 2001;36(3):189–192.
38.
FrielingHLeitmeierVHaschemi-NassabM. Reduced plasma levels of asymmetric dimethylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal. Eur Neuropsychopharmacol. 2012;22(11):836–840.
